Glukil P 2mg/500mg/15mg Tablet SR
Marketer
Volks Biotech
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glukil P 2mg/500mg/15mg Tablet SR
Diabetic patients may find relief with the Glukil P 2mg/500mg/15mg SR tablet, a triple-action medication for blood sugar management. Supplementing diet and exercise, it enhances insulin effectiveness in adult type 2 diabetics, thus reducing elevated blood glucose. Always adhere to your physician's prescribed dosage and regimen; taking it with food minimizes stomach discomfort. Missed doses should be taken promptly unless the next dose is imminent; never double the dose. Excessive intake risks hypoglycemia (low blood sugar). Concurrent use with other diabetes medication, alcohol consumption, or missed meals can trigger hypoglycemia; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function tests are typically performed before commencing therapy. Limit alcohol consumption to reduce potential side effect risks.
Primary Ingredients of Glukil P 2mg/500mg/15mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Glukil P 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glukil P 2mg/500mg/15mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Glukil P 2mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume this extended-release tablet with food.
Common Side effects of Glukil P 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glukil P 2mg/500mg/15mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Glukil P 2mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume this extended-release tablet with a meal.
How Glukil P 2mg/500mg/15mg Tablet SR works:
Glukil P 2mg/500mg/15mg Extended-Release Tablets contain glimepiride, metformin, and pioglitazone, three antidiabetic agents with distinct actions. This triple combination improves blood glucose management when single or dual drug regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glukil P 2mg/500mg/15mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glukil P 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Seek medical advice before using this drug.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glukil P tablets (2mg/500mg/15mg) are likely not suitable for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with excessively high or low blood glucose levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Glukil P 2mg/500mg/15mg SR tablets, as dosage modification may be necessary. Individuals with severe kidney disease should avoid this medication. Close monitoring of renal function is recommended during treatment. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Glukil P 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glukil P 2mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Glukil P 2mg/500mg/15mg Tablet SR :
Should you forget to take a Glukil P 2mg/500mg/15mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glukil P 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently